Medimi plans to acquire MedThings via a share issue, creating a stronger Nordic digital medication management player with significant revenue and cost synergies. The deal, valued at 97 MSEK, targets completion by December 2024.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.